Literature DB >> 965973

Fatty acid abnormality in adrenoleukodystrophy.

M Igarashi, H H Schaumburg, J Powers, Y Kishmoto, E Kolodny, K Suzuki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 965973     DOI： 10.1111/j.1471-4159.1976.tb04462.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN： 0022-3042            Impact factor:   5.372


× No keyword cloud information.
  91 in total

Review 1.  X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.

Authors:  B M van Geel; J Assies; R J Wanders; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

Review 2.  Evaluation of therapy of X-linked adrenoleukodystrophy.

Authors:  Hugo W Moser; Ali Fatemi; Kathleen Zackowski; Seth Smith; Xavier Golay; Larry Muenz; Gerald Raymond
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

3.  A mouse model for X-linked adrenoleukodystrophy.

Authors:  J F Lu; A M Lawler; P A Watkins; J M Powers; A B Moser; H W Moser; K D Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

4.  An innovative electronic health records system for rare and complex diseases.

Authors:  Alessandra C Faria-Campos; Lucas A Hanke; Paulo H S Batista; Vinicius Garcia; Sérgio V A Campos
Journal:  BMC Bioinformatics       Date:  2015-12-16       Impact factor: 3.169

5.  A family with adrenoleucodystrophy.

Authors:  R P Singh; S Deshpande; R K Marwaha; K Garg
Journal:  Indian J Pediatr       Date:  1989 Sep-Oct       Impact factor: 1.967

6.  Adrenoleukodystrophy in a mother and son.

Authors:  R H Simpson; J Rodda; C J Reinecke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

7.  Adrenoleukodystrophy without adrenal insufficiency and its magnetic resonance imaging.

Authors:  H Nishio; S Kodama; T Tsubota; T Takumi; T Takahashi; S Yokoyama; T Matsuo
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

8.  Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy.

Authors:  Quentin Raas; Malu-Clair van de Beek; Sonja Forss-Petter; Inge Me Dijkstra; Abigail Deschiffart; Briana C Freshner; Tamara J Stevenson; Yorrick Rj Jaspers; Liselotte Nagtzaam; Ronald Ja Wanders; Michel van Weeghel; Joo-Yeon Engelen-Lee; Marc Engelen; Florian Eichler; Johannes Berger; Joshua L Bonkowsky; Stephan Kemp
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

9.  Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's oil).

Authors:  M Rasmussen; A B Moser; J Borel; S Khangoora; H W Moser
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

10.  Neuronal lipidosis and neuroaxonal dystrophy in cerebro-hepato-renal (Zellweger) syndrome.

Authors:  J M Powers; R C Tummons; A B Moser; H W Moser; D S Huff; R I Kelley
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.